Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company daily Stock Chart
Eli Lilly and Company
IndexS&P 500 P/E24.29 EPS (ttm)4.64 Insider Own12.10% Shs Outstand953.70M Perf Week-0.27%
Market Cap107.58B Forward P/E17.23 EPS next Y6.55 Insider Trans-0.53% Shs Float946.87M Perf Month4.10%
Income4.44B PEG2.30 EPS next Q1.50 Inst Own81.80% Short Float1.25% Perf Quarter-2.51%
Sales22.64B P/S4.75 EPS this Y102.80% Inst Trans0.77% Short Ratio3.62 Perf Half Y-1.86%
Book/sh3.70 P/B30.49 EPS next Y12.88% ROA20.10% Target Price124.08 Perf Year2.45%
Cash/sh1.73 P/C65.08 EPS next 5Y10.55% ROE172.10% 52W Range101.36 - 132.13 Perf YTD-2.52%
Dividend2.58 P/FCF130.44 EPS past 5Y-5.30% ROI15.70% 52W High-14.63% Beta0.16
Dividend %2.29% Quick Ratio0.90 Sales past 5Y1.20% Gross Margin77.80% 52W Low11.29% ATR2.23
Employees38680 Current Ratio1.20 Sales Q/Q3.20% Oper. Margin20.00% RSI (14)54.87 Volatility2.04% 2.01%
OptionableYes Debt/Eq4.50 EPS Q/Q28.10% Profit Margin35.10% Rel Volume0.54 Prev Close113.53
ShortableYes LT Debt/Eq4.04 EarningsOct 23 BMO Payout30.30% Avg Volume3.27M Price112.80
Recom2.40 SMA201.89% SMA501.63% SMA200-2.66% Volume1,753,883 Change-0.64%
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Nov-11-19 09:28AM  4 Biotech Stocks That Could Keep Beating Wall Street Zacks
07:48AM  Eli Lilly Has the Base to Support a New Rally
Nov-08-19 12:20PM  Aduro (ADRO) Q3 Loss Wider Than Expected, Revenues Rise Y/Y Zacks
10:31AM  Corcept (CORT) Earnings Beat in Q3, Korlym Boosts Sales Zacks
06:45AM  Lilly Reinforces its Commitment to Rheumatology through Data Showcased at the ACR/ARP Annual Meeting PR Newswire
Nov-07-19 12:50PM  Lilly Announces the Pricing Terms of its Cash Tender Offer for Up to $2,000,006,000 Aggregate Principal Amount of Its Outstanding Debt Securities PR Newswire
11:13AM  Nektar (NKTR) Q3 Earnings & Revenues Top Estimates, Stock Up Zacks
09:00AM  Lilly Announces the Early Tender Results and Upsizing of Its Pending Cash Tender Offer to Up to $2,000,006,000 Aggregate Principal Amount of Its Outstanding Debt Securities PR Newswire
Nov-06-19 04:44PM  US Indexes Close Mostly Flat Wednesday
11:10AM  Radius (RDUS) Q3 Earnings Beat Estimates on Tymlos Strength Zacks
11:00AM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
09:00AM  Eli Lilly and Company to Present Multiple Abstracts for LOXO-305 at ASH 2019 PR Newswire
Nov-05-19 11:02AM  Allergan (AGN) Meets Q3 Earnings Estimates, Ups '19 Sales View Zacks
Nov-04-19 04:15PM  Lilly to Participate in Credit Suisse 28th Annual Healthcare Conference PR Newswire
01:00PM  Value Biotech ETFs & Stocks to Buy Now Zacks
11:38AM  What's in the Cards for Teva (TEVA) This Earnings Season? Zacks
10:37AM  Weekly CEO Buys Highlight
09:00AM  Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance® CNW Group
Nov-03-19 05:32PM  Top Insider Buys Highlight for the Week of Nov. 1
07:30AM  Eli Lilly CEO David Ricks and Other Insiders Are Buying the Slumping Stock
Nov-01-19 04:24PM  WeWork IPO was a Failure These 2 IPO Stocks are Surging InvestorPlace
02:16PM  The Good, Bad, and Ugly for Biogen Stock InvestorPlace
12:07PM  Agios' (AGIO) Q3 Loss Narrower Than Expected, Revenues Miss Zacks
03:35AM  UPDATE 2-Novo Nordisk nudges up 2019 sales outlook as new drugs excel Reuters
Oct-31-19 11:45AM  United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up Zacks
11:34AM  Sanofi (SNY) Q3 Earnings Beat, Vaccines/CHC Units Hurt Sales Zacks
06:30AM  Dicerna ropes in Roche on gene-silencing deal worth up to $1.67B American City Business Journals
Oct-29-19 06:41PM  Analysts Like Biogen's Chances of Getting Alzheimer's Drug Approved
04:14PM  6 Stocks With Low Price-Sales Ratios
11:10AM  Incyte (INCY) Beats on Q3 Earnings & Sales, Ups Jakafi View Zacks
09:15AM  S&P Goes Where Its Never Gone Before Zacks
05:49AM  Eli Lilly and Company -- Moody's assigns A2 rating to Eli Lilly's euro notes; stable outlook Moody's
04:59AM  5 Lagging Blue Chips That Can Lead as Investors Turn Bearish Investopedia
Oct-28-19 02:26PM  China could quickly become the worlds largest antidepressant market, but hurdles remain MarketWatch
12:06PM  Weekly CEO Buys Highlight
11:59AM  Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More Zacks
07:00AM  5 Dividend Stocks to Buy Even Though Investing Pros Are Really Gloomy
Oct-27-19 04:31PM  Top Insider Buys Highlight for the Week of Oct. 25
10:16AM  Insider Buying: The Eli Lilly and Company (NYSE:LLY) Chairman Just Bought US$500k Worth Of Shares Simply Wall St.
Oct-26-19 03:23PM  Notable Insider Buys In The Past Week: Eli Lilly, JPMorgan, Thor Industries Benzinga
Oct-25-19 10:31AM  Pharma Stock Roundup: LLY, NVS, AZN's Q3 Earnings, Updates From FDA Zacks
Oct-24-19 06:51PM  Edited Transcript of LLY earnings conference call or presentation 23-Oct-19 1:00pm GMT Thomson Reuters StreetEvents
04:29PM  Eli Lilly and Company Reaffirms Buy (LLY) Yahoo Finance
10:17AM  Lilly Announces Cash Tender Offer for Up to $2.0 Billion Aggregate Principal Amount of Its Outstanding Debt Securities PR Newswire
07:36AM  The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise Benzinga
Oct-23-19 04:03PM  Two Drugmakers Beat Earnings Forecasts So Why Did One Topple? Investor's Business Daily
01:02PM  Boeing, Caterpillar report disappointing earnings, but their shares bounce back MarketWatch
11:31AM  Two Drugmakers Beat Earnings Forecasts So Why Did One Topple? Investor's Business Daily
10:23AM  Eli Lilly to target cancer drug developers for deals Reuters
10:01AM  Lilly (LLY) Q3 Earnings Top Estimates, Sales Lag, Stock Down Zacks
08:29AM  Eli Lilly Earned More Than Expected. Heres Why the Stock Is Falling Anyway.
07:45AM  Eli Lilly (LLY) Surpasses Q3 Earnings Estimates Zacks
07:36AM  Eli Lilly Reports Mixed Q3 Earnings, Raises Guidance Benzinga
07:03AM  Eli Lilly raises earnings guidance as new drugs boost sales Financial Times
06:58AM  Eli Lilly tops profit estimates in latest quarter as revenue falls short MarketWatch
06:54AM  UPDATE 4-Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop Reuters
06:34AM  Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop Reuters
06:34AM  Eli Lilly misses sales estimates as top-seller Trulicity disappoints Reuters
06:25AM  Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance PR Newswire
06:00AM  Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno PR Newswire
05:40AM  Eli Lilly Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance
04:36AM  Stocks - Caterpillar, Eli Lilly, Texas Instruments Fall Premarket; Boeing Rises
Oct-22-19 04:44PM  [video]Eli Lilly Expected to Earn $1.40 a Share
12:23PM  2 Large-Cap Stocks Announce Dividends
11:32AM  Drug/Biotech Stock Q3 Earnings on Oct 23: LLY, ALXN & More Zacks
09:28AM  Beware Biogens Alzheimers Drug Resurrection Bloomberg
06:00AM  Eli Lilly Reports Earnings Tomorrow. Heres What to Expect.
Oct-21-19 02:45PM  Lilly Declares Fourth-Quarter 2019 Dividend PR Newswire
Oct-20-19 08:08AM  The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict Benzinga
Oct-18-19 11:22AM  New Gilead CFO: Let's Make a Deal
10:57AM  Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow Zacks
Oct-17-19 11:24AM  Lilly's Pancreatic Cancer Candidate Fails in Phase III Study Zacks
10:54AM  Can New Drugs Help Lilly (LLY) to Deliver Solid Q3 Earnings? Zacks
10:41AM  4 Biotech Stocks That Are Set to Rally, Analyst Says
Oct-16-19 10:33AM  Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth Zacks
08:34AM  U.S. Stocks Set to Fall on Renewed China Concerns
07:24AM  The S&P 500 may be one decent day of gains away from a breakout MarketWatch
07:06AM  Lilly's pancreatic cancer treatment fails late-stage study Reuters
06:57AM  Eli Lilly says late-stage trial of pancreatic cancer treatment failed to meet its main goal of overall survival MarketWatch
06:45AM  Lilly Announces Phase 3 Study in Patients with Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint of Overall Survival PR Newswire
06:10AM  How to Cut Your 2019 Tax Bill Before Its Too Late
04:15AM  Eli Lilly Phase 3 Pancreatic Cancer Study Fails to Meet Primary Endpoint
Oct-15-19 09:15AM  This is Why Eli Lilly (LLY) is a Great Dividend Stock Zacks
Oct-14-19 11:24AM  52-Week Company Lows
10:14AM  Lilly Gets FDA Approval for New Oral Tablets for Migraine Zacks
09:03AM  Eli Lilly Stock Gets 2 Pieces of Good News
Oct-13-19 05:15PM  New Sanofi CEO Looks to Shake Things Up
Oct-12-19 06:45AM  Lilly Presents Positive Results for Taltz® (ixekizumab) in Pediatric Patients with Moderate to Severe Plaque Psoriasis at the 28th Annual European Academy of Dermatology and Venereology (EADV) Congress PR Newswire
Oct-11-19 03:48PM  Lilly's REYVOW (lasmiditan), The First and Only Medicine in a New Class of Acute Treatment for Migraine, Receives FDA Approval PR Newswire
03:38PM  UPDATE 1-Eli Lilly's migraine treatment wins U.S. FDA approval Reuters
02:39PM  Eli Lilly's migraine treatment wins U.S. FDA approval Reuters
11:03AM  Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals Zacks
09:19AM  Gilead-Galapagos Report Efficacy & Safety Results on RA Drug Zacks
08:14AM  The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout Benzinga
Oct-10-19 11:26AM  Heres What Hedge Funds Think About Eli Lilly and Company (LLY) Insider Monkey
10:58AM  3 Big Drug/Biotech Stocks Set to Beat Q3 Earnings Estimates Zacks
10:34AM  J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector Zacks
09:57AM  Dermira Starts Lebrikizumab Dosing in Late-Stage Eczema Study Zacks
Oct-09-19 12:31PM  Verzenio (abemaciclib) Significantly Extends Life by a Median of 9.4 Months for Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2 Study GlobeNewswire
11:10AM  Gilead (GILD) Files NDA for RA Candidate Filgotinib in Japan Zacks
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent Bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; Avidity Biosciences, Inc.; and National Comprehensive Cancer Network. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerNov 07Sale114.3740045,749116,228,983Nov 08 10:35 AM
LILLY ENDOWMENT INC10% OwnerNov 06Sale114.05173,91819,835,000116,229,383Nov 07 11:03 AM
LILLY ENDOWMENT INC10% OwnerNov 04Sale114.047,003798,608116,403,301Nov 05 01:18 PM
LILLY ENDOWMENT INC10% OwnerOct 31Sale114.00190,00021,659,646116,410,304Nov 01 10:37 AM
Ricks David APresident & CEOOct 25Buy108.384,615500,174157,405Oct 25 12:13 PM
White Anne E.SVP & Pres-Lilly OncologyOct 25Buy108.841,000108,84022,043Oct 28 03:11 PM
Smiley Joshua LSVP and CFOOct 25Buy107.5992999,95131,524Oct 28 03:06 PM
Skovronsky DanielSVP, CSO, and Pres. LRLOct 25Buy108.615,000543,05075,818Oct 28 03:00 PM
TAI JACKSON PDirectorOct 24Buy107.491,861200,03956,440Oct 25 12:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 20Sale117.004,500526,50033,806Sep 23 03:54 PM
LILLY ENDOWMENT INC10% OwnerSep 20Sale116.37210,00024,437,726116,600,304Sep 23 01:33 PM
Fry Stephen FSVP, HR & DiversitySep 05Sale115.009,4521,086,980100,211Sep 09 12:12 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 03Sale112.9119,5002,201,74538,306Sep 04 03:09 PM
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM